Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium

NCT02124395 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT02124395
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02124395 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Health-related Quality of Life in Rare Kidney Stone Formers in the Rare Kidney Stone Consortium
Lead sponsor
NYU Langone Health
Phase
Observational
Overall status
Completed
Start date
August 31, 2013
Completion date
July 31, 2022
Enrollment
365 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adenine phosphoribosyl transferase deficiency, cystinuria, dent disease, primary hyperoxaluria